Less than half of people living with HIV in the U.S. are receiving recommended regular medical care including antiretroviral treatment, according to a study described in the January 19, 2012, advance online edition of the Journal of Acquired Immune Deficiency Syndromes .
Gilead Sciences this week announced the start of a new Phase 2 clinical trial th...
HIV RNA levels are the most significant factor predicting risk of HIV transmissi...
Oral HIV antibody testing is quick and convenient, but this method is not quite ...
Four pharmaceutical companies recently agreed to discount their prices on antire...
The U.S. Food and Drug Administration (FDA) last week announced revisions to the...
The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immun...
The following table from the U.S. Centers for Disease Control and Prevention (CD...
Having a high blood level of hepatitis B virus (HBV) DNA increases the likelihoo...
The U.S. Food and Drug Administration (FDA) last week gave the go-ahead for furt...
An investigational adenovirus-based hepatitis C virus (HCV) vaccine induced sust...
Screening all people in the U.S. in the 46 to 66 year age group for hepatitis C ...
Hepatitis C patients who develop anemia during treatment with pegylated int...
Coinfection with hepatitis B virus (HBV) nearly doubled the risk of progression ...
HIV and hepatitis C virus (HCV) experts have issued preliminary recommendations ...
Expert panels that put together the Department of Health and Human Services anti...
Reported cases of gonorrhea rose slightly and syphilis declined somewhat during ...
Oral cancers caused by oncogenic human papillomavirus (HPV) -- the same virus th...
Ribavirin, a component of standard therapy for chronic hepatitis C, may also be ...